143 related articles for article (PubMed ID: 11939755)
1. Early onset of medullary thyroid carcinoma in a kindred with multiple endocrine neoplasia type iia associated with cutaneous lichen amyloidosis.
Lemos MC; Carrilho F; Rodrigues FJ; Santos P; Carvalheiro M; Ruas MA; Regateiro FJ
Endocr Pract; 2002; 8(1):19-22. PubMed ID: 11939755
[TBL] [Abstract][Full Text] [Related]
2. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
[TBL] [Abstract][Full Text] [Related]
3. Presymptomatic DNA screening in families with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.
Frilling A; Dralle H; Eng C; Raue F; Broelsch CE
Surgery; 1995 Dec; 118(6):1099-103; discussion 1103-4. PubMed ID: 7491529
[TBL] [Abstract][Full Text] [Related]
4. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
Sansó G; Domené HM; Iorcansky S; Barontini M
Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
[TBL] [Abstract][Full Text] [Related]
5. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M
Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030
[TBL] [Abstract][Full Text] [Related]
6. Germ line mutation analysis in families with multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma.
Karga HJ; Karayianni MK; Linos DA; Tseleni SC; Karaiskos KD; Papapetrou PD
Eur J Endocrinol; 1998 Oct; 139(4):410-5. PubMed ID: 9820617
[TBL] [Abstract][Full Text] [Related]
7. Multiple endocrine neoplasia type iia: report of a family with a study of three generations in qatar.
Zirie M; Mohammed I; El-Emadi M; Haider A
Endocr Pract; 2001; 7(1):19-27. PubMed ID: 11250764
[TBL] [Abstract][Full Text] [Related]
8. A Cys634Gly substitution of the RET proto-oncogene in a family with recurrence of multiple endocrine neoplasia type 2A and cutaneous lichen amyloidosis.
Seri M; Celli I; Betsos N; Claudiani F; Camera G; Romeo G
Clin Genet; 1997 Feb; 51(2):86-90. PubMed ID: 9111993
[TBL] [Abstract][Full Text] [Related]
9. Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutation.
González-Yebra B; Medrano ME; Mantilla A; Palma V; Colin C; Hernández DM; Tapia J; Dawson B; Salcedo M
Endocr Pathol; 2003; 14(1):71-80. PubMed ID: 12746565
[TBL] [Abstract][Full Text] [Related]
10. [Prophylactic total thyroidectomy in children and adolescents with genetic mutations in the RET-protooncogene].
Spinelli C; Puccini M; Bertocchini A; Lima M; Pacini F; Miccoli P
Pediatr Med Chir; 2002; 24(1):53-7. PubMed ID: 11938683
[TBL] [Abstract][Full Text] [Related]
11. Presentation of a kindred with familial medullary thyroid carcinoma and Cys611Phe mutation of the RET proto-oncogene demonstrating low grade malignancy.
Siggelkow H; Melzer A; Nolte W; Karsten K; Hoppner W; Hufner M
Eur J Endocrinol; 2001 May; 144(5):467-73. PubMed ID: 11331212
[TBL] [Abstract][Full Text] [Related]
12. A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan.
Iihara M; Yamashita T; Okamoto T; Kanbe M; Yamazaki K; Egawa S; Yamaguchi K; Obara T
Jpn J Clin Oncol; 1997 Jun; 27(3):128-34. PubMed ID: 9255265
[TBL] [Abstract][Full Text] [Related]
13. Update on the MEN 2A c804 RET mutation: is prophylactic thyroidectomy indicated?
Frohnauer MK; Decker RA
Surgery; 2000 Dec; 128(6):1052-7;discussion 1057-8. PubMed ID: 11114642
[TBL] [Abstract][Full Text] [Related]
14. Treatment of minute medullary thyroid carcinoma in multiple endocrine neoplasia 2A families first diagnosed by DNA analysis of RET proto-oncogene mutations: a case report.
Yamashita T; Lihara M; Okamoto J; Kanbe M; Ito Y; Kawakami M; Egawa S; Yamaguchi K; Obara T
Jpn J Clin Oncol; 1997 Feb; 27(1):42-5. PubMed ID: 9070340
[TBL] [Abstract][Full Text] [Related]
15. Presymptomatic genetic screening in families with multiple endocrine neoplasia type 2.
Frilling A; Höppner W; Eng C; Mulligan L; Raue F; Broelsch CE
J Mol Med (Berl); 1995 May; 73(5):229-33. PubMed ID: 7670926
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.
Kambouris M; Jackson CE; Feldman GL
Hum Mutat; 1996; 8(1):64-70. PubMed ID: 8807338
[TBL] [Abstract][Full Text] [Related]
17. Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790/791 germline mutations.
Fitze G; Schierz M; Bredow J; Saeger HD; Roesner D; Schackert HK
Ann Surg; 2002 Nov; 236(5):570-5. PubMed ID: 12409662
[TBL] [Abstract][Full Text] [Related]
18. Total thyroidectomy for hereditary medullary thyroid carcinoma 12 years after correction of Hirschsprung's disease.
Sasaki Y; Shimotake T; Go S; Iwai N
Eur J Surg; 2001 Jun; 167(6):467-9. PubMed ID: 11471675
[No Abstract] [Full Text] [Related]
19. Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2.
Learoyd DL; Marsh DJ; Richardson AL; Twigg SM; Delbridge L; Robinson BG
Arch Surg; 1997 Sep; 132(9):1022-5. PubMed ID: 9301617
[TBL] [Abstract][Full Text] [Related]
20. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
